Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy

NCT00327223 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Metastasis

Interventions

DRUG: imexon

Sponsor

AmpliMed Corporation